Finance

Lists
RPGLIFE:NSE
RPG Life Sciences Ltd
₹ 2,805.00
+7.36%
(+192.30) 1D
8-р сарын 13, 15:30:01 (GMT+5:30)  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for RPGLIFE...
Open
₹ 2,605.50
High
₹ 2,867.00
Low
₹ 2,605.50
Mkt. cap
46.39 тэрбум
Avg. vol.
0.00
Volume
79.87 мян
Dividend
0.86%
Quarterly dividend
₹ 6.00
Ex-dividend date
2026 оны 7-р сарын 9
P/E ratio
38.78
52-wk high
₹ 3,082.00
52-wk low
₹ 1,733.00
EPS
₹ 72.34
Shares outstanding
16.54 сая
No. of employees
1 мян.
Open
₹ 2,605.50
High
₹ 2,867.00
Low
₹ 2,605.50
Mkt. cap
46.39 тэрбум
Avg. vol.
0.00
Volume
79.87 мян
Dividend
0.86%
Quarterly dividend
₹ 6.00
Ex-dividend date
2026 оны 7-р сарын 9
P/E ratio
38.78
52-wk high
₹ 3,082.00
52-wk low
₹ 1,733.00
EPS
₹ 72.34
Shares outstanding
16.54 сая
No. of employees
1 мян.
Profile
RPG Life Sciences is an Indian pharmaceutical company. Formerly known as Searle Ltd, RPG Life Sciences is part of RPG Enterprises. It has its corporate office in RPG House in Worli, Mumbai. Its three major activities are the manufacturing and marketing of bulk drugs, also known as active pharmaceutical ingredients; pharmaceutical formulation; and fermentation and biotechnology. RPGLS is present in the domestic as well as the international market. It exports its products primarily to Europe, Latin America, Australia and South East Asian countries. Wikipedia
About RPG Life Sciences Ltd
CEO-
Employees1.37 мян
Founded1993
Headquarters-
SectorPharmaceutical industry
Last report
2026 оны 7-р сарын 28
Fiscal period
Q1 2027
EPS / Est. (INR)
- / -
Revenue / Est. (INR)
1.96 тэрбум / -
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
2025 оны 9-р сар
2025 оны 12-р сар
2026 оны 3-р сар
2026 оны 6-р сар
Revenue
1.82 тэрбум
1.80 тэрбум
1.77 тэрбум
1.96 тэрбум
Cost of goods sold
665.80 сая
649.00 сая
661.00 сая
681.50 сая
Cost of revenue
665.80 сая
649.00 сая
661.00 сая
681.50 сая
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
361.60 сая
353.20 сая
570.90 сая
377.60 сая
Operating expense
812.90 сая
807.50 сая
835.00 сая
901.50 сая
Total operating expenses
1.48 тэрбум
1.46 тэрбум
1.50 тэрбум
1.58 тэрбум
Operating income
338.10 сая
343.80 сая
273.30 сая
373.90 сая
Other non operating income
45.40 сая
34.10 сая
-101.90 сая
47.00 сая
EBT including unusual items
494.50 сая
291.20 сая
402.00 сая
414.60 сая
EBT excluding unusual items
382.30 сая
375.40 сая
277.30 сая
414.60 сая
Income tax expense
126.00 сая
69.90 сая
103.00 сая
107.00 сая
Effective tax rate
25.48%
24.00%
25.62%
25.81%
Other operating expenses
399.10 сая
400.50 сая
206.70 сая
464.90 сая
Net income
368.50 сая
221.30 сая
299.00 сая
307.60 сая
Net profit margin
20.28%
12.29%
16.90%
15.72%
Earnings per share
-
-
-
-
Interest and investment income
-
-
96.70 сая
-
Interest expense
-1.20 сая
-2.50 сая
-3.90 сая
-6.30 сая
Net interest expenses
-1.20 сая
-2.50 сая
92.80 сая
-6.30 сая
Depreciation and amortization charges
52.20 сая
53.80 сая
57.40 сая
59.00 сая
EBITDA
389.90 сая
395.75 сая
325.80 сая
426.40 сая
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
Google аппс